Skip to main content
44°
Cloudy
Site search
Search
Menu
Search
Subscribe
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
Contact Us
Subscribe
News
East Greenwich Pendulum
Kent County Daily Times
Narragansett Times
NK Standard-Times
Sports
Features
Special Sections
Local Guide
Local Events
Markets & Stocks
Weather
League of Women Voters SRI
League of Women Voters WS
Classifieds
Place ad
Legal Notices
Place Kent Legal
Place SRI Class Legal
Search SRI Legals
Search Kent Legals
Obituaries
Subscribe
E-Edition
Community Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Trulieve Cannabis Corp
(OP:
TCNNF
)
5.397
-0.083 (-1.51%)
Streaming Delayed Price
Updated: 3:59 PM EST, Dec 9, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Trulieve Cannabis Corp
< Previous
1
2
3
4
5
6
7
8
9
...
41
42
Next >
The Price Is Right: This Weed Real Estate Stock Proves Conservative Strategies Bring Returns
Today 19:30 EST
New Lake Capital Partners (OTC:NLCP), a real estate company focused on cannabis properties, offers an attractive investment with a 9.1% dividend yield, well above the return on 10-year government...
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
85% Of Cannabis Companies Report Positive Earnings, But Not All Are Winning - See Who's Leading
Today 11:13 EST
85% of the companies analyzed by Beacon Securities achieved positive adjusted EBITDA for the quarter, an increase from 81% in Q2.
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Is MariMed A Safe Haven In The Wake Of Florida's Cannabis Legalization Defeat?
December 04, 2024
For investors, MariMed represents a fundamentally strong outlier, but industry-wide challenges remain a drag on stock performance.
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Pharma-Grade Cannabis Could Hit Walgreens & CVS—But Can The Industry Survive The FDA?
November 28, 2024
As the formal review process for rescheduling cannabis unfolds, industry players are closely watching its potential to transform the sector.
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Insights into Trulieve Cannabis's Upcoming Earnings
November 04, 2024
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Florida To Award 22 New Cannabis Licenses After 18-Month Wait—Legal Battles Ahead?
November 27, 2024
Florida awards 22 new medical cannabis licenses after 18 months, potentially sparking legal battles as patient numbers exceed 880,000.
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Federal Policy Could Add $3 Billion To Cannabis Industry: On Track To Reach $55 Billion By 2030
November 26, 2024
According to LeafLink, over the next 2-3 years, 5,000 non-MSO retailers are projected to open in key states, increasing store counts by 70%.
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
80% Leverage, 5.5x EBITDA: Is Cresco The High-Risk, High-Reward Play Investors Need?
November 22, 2024
According to Z&A, its enterprise value (EV) to current sales ratio stands at 1.6x, lower than Curaleaf and Green Thumb, both at 2.2x.
Via
Benzinga
Trump's Pick for Attorney General Is No Matt Gaetz When It Comes To Cannabis Reform
November 22, 2024
Trump picks Pam Bondi as new attorney general nominee, shifting focus to her record. Bondi's tough stance on cannabis contrasts with the pro-reform views of former choice, Matt Gaetz.
Via
Benzinga
Topics
Cannabis
Government
Exposures
Cannabis
Political
Best And Worst Performing States For Cannabis Sales In 2024: YTD Winners & Losers
November 21, 2024
BDSA's October 2024 data highlights Maryland as the fastest-growing state for cannabis sales, with a year-to-date increase of 57.8%.
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Cannabis Stocks Feel The Burn: Matt Gaetz Bows Out As Trump's Attorney General Nominee
November 21, 2024
The AdvisorShares Pure US Cannabis ETF (NYSEARCA: MSOS), often viewed as a benchmark for MSOs, dropped by -4.31%, closing at $4.56.
Via
Benzinga
Topics
Cannabis
ETFs
Government
Exposures
Cannabis
Political
Trulieve Cannabis Execs Buy 26K Company Shares: What Does This Mean For Investors?
November 19, 2024
Trulieve execs purchase 26,000 shares amid stock drop. Insider buys spark speculation of undervaluation despite Florida setbacks.
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Medical Marijuana Footprint Grows In Florida As Legalization Push Fizzles, And Other New Cannabis Stores
November 15, 2024
RISE Dispensaries, a cannabis retail chain owned by Green Thumb Industries Inc. (CSE: GTII) (OTCQX: GTBIF), opened RISE Dispensary Orlando on Good Homes Road on Friday, Nov. 8. Located at 725 Good...
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Ground Cannabis Dust Is A Hazardous Chemical, Confirms Massachusetts Regulator
November 14, 2024
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Trump Nominates Another Cannabis Supporter To Cabinet: Rep. Matt Gaetz For Attorney General
November 13, 2024
Donald Trump nominated Rep. Matt Gaetz as attorney general, who has supported cannabis legalization and proposed ending cannabis testing for military recruitment.
Via
Benzinga
Topics
Cannabis
Government
Exposures
Cannabis
Political
Does the Rejection of Top Marijuana Legalization Measures Doom the Pot Industry?
November 13, 2024
The American electorate seems to have turned against weed legal reform.
Via
The Motley Fool
Topics
Cannabis
Exposures
Cannabis
Cannabis Stocks Plunged After Florida Legalization Failed: Rational Reaction Or Market Overreach?
November 08, 2024
Florida's failed adult-use cannabis vote led to a $2.6B loss in market cap. Was the market reaction justified? Earnings data adds uncertainty.
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Hemp Market Surge: How New Regulations Could Impact Growth
November 08, 2024
Hemp industry regulatory changes in 2024 may impact delta-8 THC sales, spark market shifts, and intensify hemp vs. marijuana sector conflicts.
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Cannabis Stocks: Is It Time To Buy The Dip After Elections And Legalization Setbacks?
November 07, 2024
After a post-election plunge, cannabis stocks are showing signs of recovery. We analyze Tilray, SNDL, Trulieve, MSOS – time to buy the dip?
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Tilray, Trulieve And Other Cannabis Stocks Nosediving As Industry Faces New Wave Of Political Uncertainty
November 06, 2024
Cannabis stocks plunge as Florida's legalization fails and GOP Senate control tempers expectations for industry growth.
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Florida's Cannabis Initiative Defeated: Trulieve CEO Kim Rivers, NFL's Ricky Williams And Others Respond
November 06, 2024
Florida's cannabis legalization bid, Amendment 3, narrowly missed the mark. Industry leaders pledge to keep pushing for future reform efforts.
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Hemp Vs. Marijuana: Industry Tensions Rise Amid Rejection Of Cannabis Legalization In Florida, The Dakotas
November 06, 2024
Explore rising cannabis industry tensions as hemp companies clash with MSOs over market control, legalization rejections, and regulatory divides.
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Cannabis Reform Stumbles In 2024 Elections: A State-By-State Breakdown As Stocks Take A Hit
November 06, 2024
Florida and the Dakotas reject cannabis measures, while Nebraska approves medical cannabis and Dallas decriminalizes. Explore each state's path forward.
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Florida's Recreational Marijuana Measure Flames Out -- but There Is a Silver Lining
November 06, 2024
The Sunshine State's long-awaited attempt to legalize personal-use cannabis falls short, but it's not all bad news.
Via
The Motley Fool
Topics
Cannabis
Exposures
Cannabis
Cannabis Stocks React On Election Day, SNDL Surges While Trulieve Raised The Stakes
November 05, 2024
On Election Day, cannabis stocks had mixed results. SNDL soared with strong financials, while Trulieve's stock dropped while waiting Florida.
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
DeSantis 'On Wrong Side Of History' Curaleaf Chair Says, As Governor Calls Trulieve 'Big Pharma On Steroids'
November 05, 2024
Boris Jordan, founder and executive chair of Curaleaf Holdings, criticizes Governor Ron DeSantis for his opposition to cannabis legalization in Florida.
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Trulieve Cannabis Spent $48M In Q3 Campaigning For Adult- Use In Florida Increasing Net Loss By 400%
November 05, 2024
Trulieve Cannabis spent $48M in Q3 campaigning for the legalization of adult use in Florida and believes that it could be money well spent given its 156 stores there but, in the meantime, it has...
Via
Talk Markets
Topics
Cannabis
Exposures
Cannabis
Trulieve's Q3 Revenue Up Slightly Year-Over-Year, Net Loss Grows Amid $48M In Cannabis Legalization Support
November 05, 2024
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Hemp Donations Fuel DeSantis And Florida GOP's Charge Against Weed Legalization, New Findings
November 04, 2024
As Americans are preparing to head to the polls on Nov.5 to decide the winner in the 2024 race for the White House, Floridians are about to weigh in on recreational cannabis legalization as well....
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
With 200+ New Dispensaries And Four States Voting On Legalizing Cannabis, Could Market Expansion Squeeze Margins Further?
November 04, 2024
Pablo Zuanic, senior analyst at Z&A, examines key trends this quarter: dispensary saturation, price pressure, and margins amid the elections.
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
< Previous
1
2
3
4
5
6
7
8
9
...
41
42
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.